Healthcare Economist September 13, 2024
Jason Shafrin

A paper by Qato et al. (2024) quantifies the degree of of pharmacy benefit manager (PBM) market concentration.

Across all payer types, the PBM market was highly concentrated, with an HHI [Herfindahl Hirschman Index (HHI)] of 1972…the HHI was lowest in commercial insurance (1940), with 90 PBM participants, and highest in Medicare Part D (2399), with 21 PBM participants.

Three PBMs dominate in most all markets. In fact, these three large PBMs (CVS Caremark, Optum Rx, and Express Scripts) account for 73.6% of retail prescriptions filled. This does vary...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Pharma, Pharma / Biotech
Expert Discusses Changes in Diabetes Care | APhA 2025
Big pharma’s grip on health care: time for change
Potential Challenges in Using ChatGPT for Pharmacy Services
Q&A: How Pharmacists Can Make a Difference Beyond the Counter
Continuous Process Improvement: The Secret to Navigating Early-Phase Drug Development

Share This Article